Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Immuglo 5gm Solution for Infusion: Empowering the Immune System
Introduction:
Immuglo 5gm Solution for Infusion constitutes proteins derived from liquid human serum, containing antibodies from healthy adults. It is a therapeutic intervention aimed at reinforcing the immune system in individuals with a compromised immune system, enhancing the body's natural defense mechanisms.
Administration and Usage:
Administered based on the physician's instructions, Immuglo 5gm is delivered either through subcutaneous injection or slow intravenous infusion. Derived from healthy human blood rich in specific anti-infective antibodies, it is also employed to elevate platelet counts in individuals with idiopathic thrombocytopenic purpura (ITP), a blood disorder. The initiation of the medication is a gradual process, closely monitored by healthcare professionals.
Possible Side Effects:
While undergoing treatment, patients may experience side effects such as headaches, nausea, chills, fatigue, fever, upper abdominal pain, diarrhea, back pain, injection site reactions, excessive sweating, and flushing. Any discomfort associated with these side effects should be promptly communicated to the treating physician.
Benefits of Immuglo 5gm Solution for Infusion:
Immuglo 5gm Solution for Infusion serves to fortify and enhance the immune system, thereby reducing the risk of infection in individuals with compromised immunity. By stimulating the production of antibodies directed against foreign substances, it actively combats infections. Furthermore, this infusion is employed to raise platelet counts in individuals with idiopathic thrombocytopenic purpura (ITP), contributing to the prevention of bleeding and facilitating blood clot formation. It is imperative that only a qualified medical professional or doctor administers Immuglo 5gm Solution for Infusion.